Video

Episode 15- Assessing the Factors at Increased Risk for Cardiometabolic Events

When assessing what population is at an increased risk for developing a cardiometabolic event, Kenneth L. Schaecher, MD, FACP, CPC, explains that the patient who is disengaged is at the greatest risk. Dr Schaecher states that patients who do not make lifestyle changes and patients who are not adherent to their medicines are examples of disengaged patients.

Furthermore, the panelists discuss the cardiometabolic conditions that result in the greatest costs to managed care facilities. Dr Schaecher explains that diabetes is number 1.

Yehuda Handelsman, MD, FACP, FACE, FNLA, explains that while commonly overlooked, kidney disease is also a component of cardiovascular disease (CVD). Dr Handelsman believes that the outcomes of kidney disease pass beyond diabetes, but the condition is commonly overlooked because less patients present with kidney disease than diabetes.

Dr Schaecher concludes that patients need to have a better understanding of how kidney disease links to cardiometabolic events.


Related Videos
Crystal S. Denlinger, MD, FACP, CEO of the National Comprehensive Cancer Network
Michael A. Choti, MD, MBA
Matthew Callister, MD
Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council
ISPOR 2024 Recap
Phaedra Corso, PhD, associate vice president for research at Indiana University
Julie Patterson, PharmD, PhD
Nancy Dreyer, MPH, PhD, FISE, chief scientific advisor to Picnic Health
Seth Berkowitz, MD, MPH, associate professor of medicine, University of North Carolina at Chapel Hill
Related Content
CH LogoCenter for Biosimilars Logo